19-7917516-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001195259.2(TGFBR3L):āc.641G>Cā(p.Ser214Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,524,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001195259.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBR3L | NM_001195259.2 | c.641G>C | p.Ser214Thr | missense_variant | 3/6 | ENST00000565886.2 | NP_001182188.1 | |
TGFBR3L | XM_011527610.3 | c.719G>C | p.Ser240Thr | missense_variant | 2/4 | XP_011525912.1 | ||
TGFBR3L | XM_011527613.3 | c.719G>C | p.Ser240Thr | missense_variant | 2/5 | XP_011525915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR3L | ENST00000565886.2 | c.641G>C | p.Ser214Thr | missense_variant | 3/6 | 5 | NM_001195259.2 | ENSP00000457962 | P1 | |
TGFBR3L | ENST00000564348.5 | n.139G>C | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000172 AC: 2AN: 116224Hom.: 0 AF XY: 0.0000155 AC XY: 1AN XY: 64316
GnomAD4 exome AF: 0.0000146 AC: 20AN: 1372686Hom.: 0 Cov.: 32 AF XY: 0.0000133 AC XY: 9AN XY: 677274
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.641G>C (p.S214T) alteration is located in exon 3 (coding exon 3) of the TGFBR3L gene. This alteration results from a G to C substitution at nucleotide position 641, causing the serine (S) at amino acid position 214 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at